Ticagrelor better than clopidogrel in early invasive treatment of ACS

20 January 2010 | by Nicola Garrett Print this article Comments Share this article
A sub-analysis of the PLATO study shows the platelet inhibitor ticagrelor is superior to clopidogrel among acute coronary syndromes (ACS) patients due to undergo invasive management....

Want to read complete article? Please Sign in or Register.

Journals

Members of Cardiology Update can access the following journals for free:

Recent comments

Most viewed articles this week

Related sites